treatment
Donanemab for Alzheimer's Gets Unanimous Thumbs Up From FDA Panel
Posted in Medicine, Science on 13th Jun, 2024
by Alex Muller
If approved, donanemab will expand the first class of disease-modifying drugs, serving as the building blocks for future generations of drugs.